PATTERNS OF PROGRESSION IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA FOLLOWING TREATMENT WITH HIGH-DOSE METHOTREXATE

被引：0

作者：

Cappelli, Louis ^{[1
]}

Newman, Jennifer ^{[1
]}

Sharif, Muhammad ^{[1
]}

Kayne, Allison ^{[1
]}

Epperla, Narendranath ^{[2
]}

Elguindy, Ahmed ^{[2
]}

Palmer, Joshua ^{[3
]}

Alnahhas, Iyad ^{[1
]}

Shi, Wenyin ^{[1
]}

机构：

[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA

[2] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

[3] Ohio State Univ, James Canc Hosp, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH USA

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NCOG-40

引用

页数：1

共 50 条

[21] Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphoma
Zhang, Joy C.
Stotts, Matthew J.
Horton, Bethany
Schiff, David
NEURO-ONCOLOGY PRACTICE, 2023, 10 (03) : 291 - 300
[22] HEPATOTOXICITY FROM HIGH-DOSE METHOTREXATE IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Zhang, Joy C.
Horton, Bethany J.
Stotts, Matthew J.
Schiff, David
GASTROENTEROLOGY, 2022, 162 (07) : S1284 - S1285
[23] High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
Yasufumi Masaki
Miyuki Miki
Yue Sun
Takuji Nakamura
Haruka Iwao
Akio Nakajima
Nozomu Kurose
Tomoyuki Sakai
Zhe-Xiong Jin
Toshioki Sawaki
Takafumi Kawanami
Yoshimasa Fujita
Masao Tanaka
Toshihiro Fukushima
Yuko Hirose
Hisanori Umehara
International Journal of Hematology, 2011, 93 : 720 - 726
[24] High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
Masaki, Yasufumi
Miki, Miyuki
Sun, Yue
Nakamura, Takuji
Iwao, Haruka
Nakajima, Akio
Kurose, Nozomu
Sakai, Tomoyuki
Jin, Zhe-Xiong
Sawaki, Toshioki
Kawanami, Takafumi
Fujita, Yoshimasa
Tanaka, Masao
Fukushima, Toshihiro
Hirose, Yuko
Umehara, Hisanori
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (06) : 720 - 726
[25] Treatment of Primary Central Nervous System Lymphoma with High-dose Methotrexate and Radiotherapy in HIV-negative Patients
Jalaeikhoo, Hasan
Yekaninejad, Mir Saeed
Hajizamani, Saeideh
Rahim, Fakher
Ahmedzadesh, Ahmed
Keyhani, Manoutchehr
Hariri, Behrooz Sadeghi
Saki, Najmaldin
ARCHIVES OF IRANIAN MEDICINE, 2015, 18 (09) : 577 - 581
[26] Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma
Joerger, M.
Huitema, A. D. R.
Illerhaus, G.
Ferreri, A. J. M.
LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 1867 - 1875
[27] High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma
Akiyama, Hiroki
Takase, Hiroshi
Kubo, Fumito
Miki, Tohru
Yamamoto, Masahide
Tomita, Makoto
Mochizuki, Manabu
Miura, Osamu
Arai, Ayako
CANCER SCIENCE, 2016, 107 (10) : 1458 - 1464
[28] Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma
Seiichiro Hirono
Yasuo Iwadate
Yoshinori Higuchi
Toru Serizawa
Osamu Nagano
Tomoro Matsutani
Naokatsu Saeki
Journal of Neuro-Oncology, 2015, 123 : 237 - 244
[29] Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma
Hirono, Seiichiro
Iwadate, Yasuo
Higuchi, Yoshinori
Serizawa, Toru
Nagano, Osamu
Matsutani, Tomoro
Saeki, Naokatsu
JOURNAL OF NEURO-ONCOLOGY, 2015, 123 (02) : 237 - 244
[30] PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: HIGH-DOSE METHOTREXATE PLUS RADIOTHERAPY, BETTER TREATMENT FOR ALL?
Gonzalez-Domingo, M.
Gonzalez-San Segundo, C.
Menarguez, J.
RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S361 - S362

← 1 2 3 4 5 →